New Drug Approved for Gaucher Disease Type 1 — Physician’s First Watch
August 21, 2014
New Drug Approved for Gaucher Disease Type 1
By the Editors
The FDA has approved eliglustat (Cerdelga) to treat adults with Gaucher disease type 1. The oral drug slows production of fatty material that can collect in a patient's spleen, liver, and bone marrow.